Skip to main content
Clinical Trials/ISRCTN38851969
ISRCTN38851969
Completed
未知

Testing the effectiveness, acceptability and feasibility of DIALOG+ in severe mental illness in Argentina: a non-controlled trial

Queen Mary University of London0 sites40 target enrollmentDecember 16, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients with severe mental illness (specifically anxiety disorders)
Sponsor
Queen Mary University of London
Enrollment
40
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 16, 2019
End Date
March 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 18/12/2020:
  • 1\. Primary diagnosis of an anxiety disorder
  • 2\. Aged 18\-65 years old
  • 3\. Capacity to provide informed consent
  • 4\. Score of 5 or below on the MANSA scale
  • 5\. Receiving care from a participating health care provider
  • Previous inclusion criteria:
  • 1\. Primary diagnosis of severe mental illness as defined by ICD10: F20\-9, F31, F32
  • 2\. Aged 18\-65 years old
  • 3\. Capacity to provide informed consent

Exclusion Criteria

  • 1\. Diagnosis of dementia or organic psychosis as determined by their health providers
  • 2\. Primary diagnosis of substance use disorder
  • 3\. Severe learning difficulties or severe cognitive disability

Outcomes

Primary Outcomes

Not specified

Similar Trials